glp-1 drugs and alzheimer's improves the neuronal supportive ability of astrocytes in disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway GLP-1 mimetics and cognition -

In a phase 2 trial involving people with obesity, the 12 mg weekly dose of retatrutide resulted in a placebo-adjusted mean weight reduction of 22.1% after 48 weeks of treatment

Accelerated demand after Mounjaros launch Even before Mounjaros momentous debut, Ozempic demonstrated notable HbA1c reductions and weight loss results, and demand for GLP-1s grew at a steady rate (compound monthly growth of 2% from January 2020 to May 2021)

doi: 10.1056/NEJMoa1616011 41 MannJ

Lancet 400 , 18691881 (2022)

Patients in Frederick, MD, can receive a customized weight loss plan designed to support appetite control, healthier eating habits, and steady progress over time